Traws Pharma (TRAW) Assets (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Assets of $8.2 million for Q1 2026, down 57.22% year-over-year from $19.1 million in Q1 2025, and down 23.18% quarter-over-quarter from $10.6 million in Q4 2025.
Traws Pharma (TRAW) Assets (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Assets for 15 consecutive years, with $8.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 57.22% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (down 57.22% YoY), while the FY2025 annual figure was $10.6 million, down 57.47% from the prior year.
- Assets slipped to $8.2 million in Q1 2026 per TRAW's latest filing, from $10.6 million in the prior quarter.
- Across five years, Assets topped out at $51.4 million in Q1 2022 and bottomed at $8.2 million in Q1 2026.
- Historically, Assets has averaged $25.6 million across 5 years, with a median of $22.7 million in 2023.
- Annual changes were most pronounced in 2024 — Assets sank 66.95% — and 2025, when it surged 39.25%.
- Traws Pharma's Assets stood at $39.4 million in 2022, then sank by 42.39% to $22.7 million in 2023, then gained by 10.05% to $25.0 million in 2024, then slumped by 57.47% to $10.6 million in 2025, then fell by 23.18% to $8.2 million in 2026.
- Business Quant data shows TRAW's Assets at $8.2 million in Q1 2026, $10.6 million in Q4 2025, and $12.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | 11.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.16 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Sep 30, 2025 | 12.44 Mn |
| Jun 30, 2025 | 15.62 Mn |
| Mar 31, 2025 | 19.06 Mn |
| Dec 31, 2024 | 24.96 Mn |
| Sep 30, 2024 | 8.94 Mn |
| Jun 30, 2024 | 18.69 Mn |
| Mar 31, 2024 | 18.17 Mn |
| Dec 31, 2023 | 22.68 Mn |
| Sep 30, 2023 | 27.04 Mn |
| Jun 30, 2023 | 30.47 Mn |
| Mar 31, 2023 | 35.06 Mn |
| Dec 31, 2022 | 39.37 Mn |
| Sep 30, 2022 | 43.78 Mn |
| Jun 30, 2022 | 48.07 Mn |
| Mar 31, 2022 | 51.42 Mn |
| Dec 31, 2021 | 55.48 Mn |
| Sep 30, 2021 | 59.99 Mn |
| Jun 30, 2021 | 44.38 Mn |